The role of glycosphingolipid metabolism in the developing brain
- PMID: 18845618
- PMCID: PMC2674698
- DOI: 10.1194/jlr.R800028-JLR200
The role of glycosphingolipid metabolism in the developing brain
Abstract
Glycosphingolipids (GSLs) are amphipathic lipids ubiquitously expressed in all vertebrate cells and body fluids, but they are especially abundant in the nervous system. The synthesis of GSLs generally is initiated in the endoplasmic reticulum and completed in the Golgi apparatus, followed by transportation to the plasma membrane surface as an integral component. The amount and expression patterns of GSLs change drastically in brains during the embryonic to postnatal stages. Recent studies have revealed that GSLs are highly localized in cell surface microdomains and function as important components that mediate signal transduction and cell adhesion. Also in developing brains, GSLs are suggested to play important roles in nervous system formation. Disturbance of GSL expression and metabolism affects brain function, resulting in a variety of diseases, particularly lysosomal storage diseases. In this review, we describe some aspects of the roles of GSLs, especially of gangliosides, in brain development.
Figures
Similar articles
-
Multi-system disorders of glycosphingolipid and ganglioside metabolism.J Lipid Res. 2010 Jul;51(7):1643-75. doi: 10.1194/jlr.R003996. Epub 2010 Mar 8. J Lipid Res. 2010. PMID: 20211931 Free PMC article. Review.
-
Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains.J Neurochem. 2007 Dec;103(6):2327-41. doi: 10.1111/j.1471-4159.2007.04910.x. Epub 2007 Sep 19. J Neurochem. 2007. PMID: 17883393
-
Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs).Adv Neurobiol. 2023;29:333-390. doi: 10.1007/978-3-031-12390-0_12. Adv Neurobiol. 2023. PMID: 36255681
-
Glycosphingolipid metabolism in cell fate specification.J Cell Sci. 2018 Dec 17;131(24):jcs219204. doi: 10.1242/jcs.219204. J Cell Sci. 2018. PMID: 30559216 Review.
-
Traveling for the glycosphingolipid path.Glycoconj J. 2000 Jul-Sep;17(7-9):627-47. doi: 10.1023/a:1011086929064. Glycoconj J. 2000. PMID: 11421354 Review.
Cited by
-
Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.Adv Cancer Res. 2013;117:59-89. doi: 10.1016/B978-0-12-394274-6.00003-0. Adv Cancer Res. 2013. PMID: 23290777 Free PMC article. Review.
-
The Angelman syndrome protein Ube3a/E6AP is required for Golgi acidification and surface protein sialylation.J Neurosci. 2013 Feb 27;33(9):3799-814. doi: 10.1523/JNEUROSCI.1930-11.2013. J Neurosci. 2013. PMID: 23447592 Free PMC article.
-
Caveolin 1 is required for axonal outgrowth of motor neurons and affects Xenopus neuromuscular development.Sci Rep. 2020 Oct 5;10(1):16446. doi: 10.1038/s41598-020-73429-x. Sci Rep. 2020. PMID: 33020520 Free PMC article.
-
Heat shock protein-based therapy as a potential candidate for treating the sphingolipidoses.Sci Transl Med. 2016 Sep 7;8(355):355ra118. doi: 10.1126/scitranslmed.aad9823. Sci Transl Med. 2016. PMID: 27605553 Free PMC article.
-
Multi-system disorders of glycosphingolipid and ganglioside metabolism.J Lipid Res. 2010 Jul;51(7):1643-75. doi: 10.1194/jlr.R003996. Epub 2010 Mar 8. J Lipid Res. 2010. PMID: 20211931 Free PMC article. Review.
References
-
- Hakomori S. 1990. Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J. Biol. Chem. 265 18713–18716. - PubMed
-
- Yu, R. K., M. Yanagisawa, and T. Ariga. 2007. Glycosphingolipid structures. In Comprehensive Glycoscience. J. P. Kamerling, editor. Elsevier, Oxford. 73–122.
-
- Yanagisawa M., and R. K. Yu. 2007. The expression and functions of glycoconjugates in neural stem cells. Glycobiology. 17 57R–74R. - PubMed
-
- Yu, R. K., T. Ariga, M. Yanagisawa, and G. Zeng. 2008. Biosynthesis and degradation of gangliosides in the nervous system. In Glycoscience. B. O. Fraser-Reid, K. Tatsuka, and J. Thiem, editors. Springer Berlin-Heidelberg, Germany. 1671–1695.
-
- Hanada K., K. Kumagai, S. Yasuda, Y. Miura, M. Kawano, M. Fukasawa, and M. Nishijima. 2003. Molecular machinery for non-vesicular trafficking of ceramide. Nature. 426 803–809. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
